One of the few constants in the evolving government enforcement landscape is a focus on life sciences companies and their interactions and financial relationships with providers. In this final installment of our three-part Healthcare Litigation, Compliance & Enforcement webinar series, please join our white collar, life sciences and healthcare partners for a discussion of key enforcement risks facing life sciences companies.
During the session, we will offer practical tips on how to fine-tune compliance efforts in areas that are often scrutinized by the government and whistleblowers. Topics will include:
- In-person speaker programs, post-COVID-19
- Emerging issues in financial relationships with healthcare providers
- Patient-support programs
- Digital health and clinical decision support
- Social media, influencers, embedded marketing and AI-driven marketing